Watch for More Frequent Fine-Tuning of Rheumatoid Arthritis Meds

June 2016

Recent guidelines will lead to more aggressive treatment of rheumatoid arthritis (RA) to suppress symptoms and slow joint damage.

Continue to recommend methotrexate first as the "anchor" drug.

If this isn't enough, suggest adding one or two other traditional disease-modifying antirheumatic drugs (DMARDs) such as sulfasalazine or hydroxychloroquine...or adding a biologic DMARD (Enbrel, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Hypertension Recommend a Systolic BP = 120 mmHg for Appropriate High Risk Patients
Diabetes Lean Away From Gliptins in Heart Failure
Infectious Diseases Consider Antibiotics a Suspect for Causing CNS Effects
Pediatrics Be Aware that Abilify is Linked to Uncontrollable Gambling and Hypersexuality
Pediatrics Look for Recent Antibiotic Use in Children With a UTI
Antithrombotics Expect Some Stent Patients to Use Two Antiplatelet Meds Less Than 12 Months
Hypertension Suggest Viacoram For Hypertensive Patients Needing Combo Therapy
Contraceptives Dispel Myths About Intrauterine Contraceptives.
Rheumatology Watch for More Frequent Fine-Tuning of Rheumatoid Arthritis Meds
Cardiology Recommend Using an ACEI or ARB Instead of Aliskiren (Rasilez)
Women's Health Avoid Even One Dose of Fluconazole in Pregnant Women

Watch for More Frequent Fine-Tuning of Rheumatoid Arthritis Meds

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents